THE BARCELONA CLINIC LIVER CANCER PRESENTS A SPECIAL COURSE ON PROGRAM FOR THE ADVANCEMENT OF THERAPY IN HEPATOCELLULAR CARCINOMA (PATH) 3–4 MART 2014 BARCELONA, SPAIN Hepatosellüler karsinoma (PATH) içinde Tedavisi İlerlemesi İçin Program Barselona, İspanya Barcelona Hastanesi Kliniğinde Karaciğer Kanseri için Barselona Kliniği (BCLC) de yapılacaktır. PATH Programın amacı, HCC tedavisinde uzman ve araştırma ya da HCC yönetimini geliştirmek atılım klinik uygulamaları ile HCC yönetimi ilerleyen onların liderlik için tanınan mükemmeliyet merkezleri arasındaki iyi uygulamaların alışverişini kolaylaştıran bir forum oluşturmaktır. AGENDA Monday 3 March 2014 J. Bruix, Chair 09:00-09:10 Welcome and Introduction J. Bruix 09:10-09:45 Current Risk Factors for HCC and Changing Epidemiology Profile M. Beaugrand 09:45-10:15 Expected Impact of Novel Antivirals in HCC Epidemiology and Management M. Colombo 10:15-10:30 Questions & Answer for Dr. Beaugrand and Dr. Colombo 10:30 – 11:00 Molecular Mechanisms in Preclinical Models and Genomic Profiling J. M. Llovet 11:00 – 11:15 Question & Answer 11:15 - 11:45 Coffee Break 11:45 - 12:15 Screening Strategies and Their Cost-Effectiveness A.Forner 12:15 – 12:45 Diagnosis, Staging and Evaluation of response to treatment by Radiology C.Ayuso 12:45 - 13:00 Question & Answer 13:00 - 14:00 Lunch and Group Photo 14:00-14:30 Case Studies: Diagnosis and Staging of HCC J. Bruix, A. Liccioni, M. Solé, and C. Ayuso 14:30-15:15 Systemic Therapies in the Management of Advanced HCC: Current Status and Future Perspectives M. Reig 15:15 – 15:45 Controversial Scenarios in Staging and Treatment Indication in Intermediate-Advanced HCC B. Sangro 15:45 – 16.30 Case Studies: Management of Intermediate-Advanced HCC (Including Stage Migration Concept) J. Bruix, M. Reig, and A. Darnell Tuesday 4 March 2014 C. Bru, Chair 09:00-09:30 Novel imaging techniques for HCC Management J. Rimola 9:30 – 9:45 Questions & Answers 09:45-10:15 Current Perspectives on Ablation for the Treatment of HCC L. Bianchi 10:15-10:45 Current Perspectives on TACE for the Treatment of HCC M. Burrel 10:45-11:15 Radioembolization: Conventional Practice or Research? S. Bhoori 11:15-11:30 Questions and Answers: Locoregional Approaches 11:30-12:00 Coffee Break 12:00-12:30 Resection and OLT: Restriction versus Expansion P. Majno 12:30 – 12:45 Question and Answer 12:45 - 13:15 Tumor angiogenesis- translational aspects and clinical implications of HCC management D. Semela 13:15 – 13:30 Questions & answers 13:30 - 14:30 Lunch 14:30 - 15:15 Challenging the Dogma in HCC Management J. Bruix 15:15 - 15:45 Intrahepatic cholangiocarcinoma: a review J. Maurel 15:45 - 16:15 Viral Issues in Systemic Treatment and Liver Transplantation X. Forns 16:15 – 16:30 16:30 - 17:00 Question and Answers Prevention of Variceal Bleeding in HCC Patients J. Bosch 17:00 – 17:15 Questions and Answers 17:15 – 17:45 Future Prospects in HCC Research J. Bruix 17:45 Closing Remarks and Farewell Visit to the research facilities (Dr. Boix) and Radiology Departments (Dr. Liccioni and Dr. Vilana) at the close of today’s session
© Copyright 2024 ExpyDoc